Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $2.9484 per EA under NDC 68001062304. Its NADAC has been published 66 times since Mar 26, 2025.
The High Outlier badge above means this manufacturer's average price in the Imatinib Mesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001062304
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212773On Market Since
12/6/2024
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 66 times since Mar 26, 2025, and over the history we have for it it has risen 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $2.6303 (May 21, 2025) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $3.0059 |
| Average price | $2.9580 |
| Largest weekly change | +9.1% (Aug 20, 2025) |
| Weeks tracked | 66 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by BluePoint Laboratories, is $2.9484 per EA (NDC 68001062304), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 8.6%. It has been tracked across 66 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Mar 26, 2025, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $2.6303 (May 21, 2025) to a high of $3.2150 (Mar 11, 2026), with a median of $3.0059 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
5 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 400 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 68001062304) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification